Advertisement

Picture EBD Group BioPharm America 2018 Boston Partnering 600x60px
Person › Details

Detlev Mennerich (Boehringer Ingelheim Venture Fund (BIVF))

Mennerich, Detlev (Boehringer Ingelheim 201604 Investment Manager at BIVF)

 

Organisation Organisation Boehringer Ingelheim Venture Fund (BIVF)
Products Product venture capital
  Product 2 LIFE SCIENCES
     

OBN (UK) Ltd.. (4/28/16). "Press Release: Elasmogen Winner of the Perfect Pitch at the 2016 BioTrinity Conference in London". London.

OBN - the membership organisation supporting the UK’s emerging life sciences companies, announces today that the winner of the Perfect Pitch Competition, taking place at BioTrinity its annual conference in London for the first time on 27th April 2016, was Elasmogen Ltd. This fast-paced, interactive and lively session saw nine emerging UK R&D companies pitch in front of a panel of seasoned investors including:

> Kate Bingham, Managing Partner, SV Life Sciences

> Maina Bhaman, Director of Healthcare Investments, Imperial Innovations

> David Phillips, Partner, SR One

> Graeme Martin, President & CEO, Takeda Ventures Inc.

> Naveed Siddiqi, Partner, EdRIP

> Detlev Mennerich, Investment Manager, Boehringer Ingelheim Ventures


The judges selected Elasmogen to win the coveted Perfect Pitch winner’s certificate which also included a 30-munite masterclass with the host and panel members. Dr Caroline Barelle, CEO of Elasmogen, presented in a three minute pitch on their proprietary soloMER™ technology that exploits the power of biologics as drugs but in a small (1/12 the size of an antibody), stable format that enables site specific delivery through complex and challenging environments like the eye and gut

Kate Bingham, Managing Partner at SV Life Sciences and Chair of the Perfect Pitch session, said “Elasmogen was selected based on its confidence, style and pitch. All the judges were very impressed by Caroline as well as the other contestants. The passion and energy they all brought to communicating their vision for their business was only surpassed by the quality of their science. Hopefully the relationships they have made during BioTrinity will help them successfully advance their products and innovations.”

John Harris, CEO of OBN, commented, “We applaud the talented individuals that competed in this challenge and the high quality of their pitches. This competition, the first organised at BioTrinity, aims to put these emerging UK life sciences companies on the right track to move their innovation forward.”

The ten companies, that presented their innovation included:
Alfacyte, BeamLine Diagnostics, Curileum Discovery, DJS Antibodies, Elasmogen, NALIA Systems, NeRRe Therapeutics, Ryboquin Company and Somanautix


The End


Contacts

OBN
John Harris, CEO, OBN
Tel: +44 (0)7881 675990
Email: john.harris@obn.org.uk

Citigate Dewe Rogerson
Sylvie Berrebi, Katja Stout
Tel: +44 (0)20 7638 9571
Email: Sylvie.Berrebi@citigatedr.co.uk, katja.stout@citigatedr.co.uk


About OBN

OBN is the Membership organisation supporting and bringing together the UK’s innovative life sciences companies, corporate partners and investors. Our 400-plus member companies are located across the Golden Triangle and beyond to Nottingham, Manchester and Scotland and benefit from our networking, partnering, purchasing, advising and advocacy activities. OBN is best known for its delivery of BioTrinity (the 11th edition is on 8-10 May 2017) Europe’s leading life sciences investment and biopartnering conference.

Further information about OBN’s tailored networking and partnering events, purchasing consortium, advice, consultancy services and advocacy activities is available on OBN’s website www.obn.org.uk

   
Record changed: 2018-03-22

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px


More documents for Detlev Mennerich


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px




» top